Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
life sciences
4
×
national blog main
boston top stories
clinical trials
biotech ipos
boston
cancer diagnostics
fda
freenome
grail
liquid biopsy
medical device
rare disease drugs
san francisco blog main
san francisco top stories
thrive earlier detection
480 biomedical
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
aprea therapeutics
arimoclomol
arnold levine
arsenal medical
baker brothers
bob langer
boehringer ingelheim
cancer
cdg therapeutics
chronic rhinosinusitis
cirina
covid-19
daiichi sankyo
deals
decheng capital
deerfield capital
diabetic macular edema
What
company
4
×
developing
4
×
ipo
tests
blood
cancer
million
public
raised
therapeutics
announced
area
based
bay
biopsy
biotech
brings
broader
buildout
close
debut
detect
disorders
drug
dyne
dyne’s
files
firm
firms
genetic
genomic
grail
intended
investors
join
late
life
liquid
lucence
lyra
Language
unset
Current search:
company
×
developing
×
" life sciences "
×
" boston blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow